3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis.
Structure-activity relationship studies, focused on identification of the active pharmacophore fragments in a single high-throughput screening calcilytic hit, resulted in the discovery of potent calcium receptor antagonists, substituted 3H-quinazolin-4-ones.